tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid

C30H29N3O5S — CID 67621470

IUPACtert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid
SMILESCC(C)(C)N(CC#Cc1ccc(Cc2nc(-c3ccccc3)c(-c3ccc(S(N)(=O)=O)cc3)o2)cc1)C(=O)O
InChIInChI=1S/C30H29N3O5S/c1-30(2,3)33(29(34)35)19-7-8-21-11-13-22(14-12-21)20-26-32-27(23-9-5-4-6-10-23)28(38-26)24-15-17-25(18-16-24)39(31,36)37/h4-6,9-18H,19-20H2,1-3H3,(H,34,35)(H2,31,36,37)
InChIKeyDIOLIQXMNBGFAD-UHFFFAOYSA-N
MW543.65 g/mol
LogP5.38
Rot. Bonds6

About tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid

tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid (PubChem CID 67621470) has the molecular formula C30H29N3O5S and a molecular weight of 543.65 g/mol. Its IUPAC name is tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid.

Molecular Properties

Compound Nametert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid
PubChem CID67621470
Molecular FormulaC30H29N3O5S
Molecular Weight543.65 g/mol
Exact Mass543.18
IUPAC Nametert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid
SMILESCC(C)(C)N(CC#Cc1ccc(Cc2nc(-c3ccccc3)c(-c3ccc(S(N)(=O)=O)cc3)o2)cc1)C(=O)O
InChIInChI=1S/C30H29N3O5S/c1-30(2,3)33(29(34)35)19-7-8-21-11-13-22(14-12-21)20-26-32-27(23-9-5-4-6-10-23)28(38-26)24-15-17-25(18-16-24)39(31,36)37/h4-6,9-18H,19-20H2,1-3H3,(H,34,35)(H2,31,36,37)
InChIKeyDIOLIQXMNBGFAD-UHFFFAOYSA-N
XLogP5.38
TPSA126.73 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms39
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500543.65
LogP ≤ 55.38
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid?
The IUPAC name of tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid (CID 67621470) is tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid.
What is the SMILES notation for tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid?
The canonical SMILES for tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid is CC(C)(C)N(CC#Cc1ccc(Cc2nc(-c3ccccc3)c(-c3ccc(S(N)(=O)=O)cc3)o2)cc1)C(=O)O.
What is the InChIKey of tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid?
The InChIKey is DIOLIQXMNBGFAD-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H29N3O5S/c1-30(2,3)33(29(34)35)19-7-8-21-11-13-22(14-12-21)20-26-32-27(23-9-5-4-6-10-23)28(38-26)24-15-17-25(18-16-24)39(31,36)37/h4-6,9-18H,19-20H2,1-3H3,(H,34,35)(H2,31,36,37).
What are the key properties of tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid?
tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid has a molecular weight of 543.65 g/mol, XLogP of 5.38, 6 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for tert-butyl-[3-[4-[[4-phenyl-5-(4-sulfamoylphenyl)-1,3-oxazol-2-yl]methyl]phenyl]prop-2-ynyl]carbamic acid is sourced from PubChem (CID 67621470), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).